[arcanemachiner]

The median income in America is a little under $40000 per person[1], so that $2.2 million pretty much represents the entire financial income of the average American over a working lifetime (55-60 years).

So in essence, you'd be trading the equivalent of one person's entire lifetime of productivity in exchange for the first generation of a radical new medicine whose outcome is unknowable.

I don't think it's crass to err on the side of caution for such a scenario.

[1] https://en.m.wikipedia.org/wiki/Per_capita_personal_income_i...

[vidarh]

These people mostly do get treatment now, for decades, involving regular expensive long term hospital stays. So you're trading already expensive treatments that cut their earnings potential drastically both by cutting number of productive years but also due to extensive sick leave.

So if there even is an increase in the total cost of treatments, it's not at all a given it's a a net increase once account for decades of additional working life.

[imtringued]

I see you are a fan of the MAiD program in Canada.